Recombinant Mouse RING finger protein 222 (Rnf222) is a protein encoded by the Rnf222 gene in mice. RING finger proteins are known for their role in ubiquitination processes, which are crucial for protein degradation and signaling pathways. The RING domain is a motif that facilitates interactions with ubiquitin-conjugating enzymes (E2s), enabling the transfer of ubiquitin to target proteins. This process can lead to various cellular outcomes, including protein degradation, localization, and activity modulation.
The RING finger domain is characterized by a specific arrangement of cysteine and histidine residues that coordinate two zinc ions, forming a stable structure essential for its function. Rnf222, like other RING finger proteins, is predicted to participate in protein-protein interactions and possibly in the regulation of cellular processes through ubiquitination.
While specific functional partners for mouse Rnf222 are not extensively documented, studies on human RNF222 suggest interactions with various proteins. For example, human RNF222 is predicted to interact with proteins such as SEZ6L, TMEM220, ZZEF1, and PI15, based on coexpression and cooccurrence analyses . These interactions may provide insights into potential roles in cellular processes, although direct evidence for mouse Rnf222 is limited.
Mouse Rnf222 is expressed across multiple embryonic and adult tissues, including the ectoderm, endoderm, mesoderm, and various organ systems like the nervous, cardiovascular, and reproductive systems . This broad expression suggests a role in fundamental cellular processes or developmental stages.
Understanding the function of Rnf222 could have implications for research into developmental biology, disease modeling, and potentially therapeutic applications. For instance, if Rnf222 is involved in ubiquitination pathways, it might influence protein stability or signaling in disease contexts.
| Protein Name | Description | Score |
|---|---|---|
| SEZ6L | Seizure 6-like protein; contributes to specialized endoplasmic reticulum functions in neurons. | 0.574 |
| TMEM220 | Transmembrane protein 220. | 0.526 |
| ZZEF1 | Zinc finger ZZ-type and EF-hand domain containing 1. | 0.477 |
| SAMD1 | Atherin; may play a role in atherogenesis. | 0.471 |
| PI15 | Peptidase inhibitor 15; serine protease inhibitor involved in facial patterning. | 0.454 |
| PLA2G4D | Cytosolic phospholipase A2 delta; hydrolyzes glycerophospholipids. | 0.454 |
| CUZD1 | CUB and zona pellucida-like domain-containing protein 1; involved in cell attachment and proliferation. | 0.432 |
| CYP4F8 | Cytochrome P450 4F8; metabolizes polyunsaturated fatty acids. | 0.428 |
| MUC15 | Mucin-15; involved in cell adhesion to the extracellular matrix. | 0.425 |
| GABRP | Gamma-aminobutyric acid receptor subunit pi; involved in neuronal inhibition. | 0.413 |
Note: The table refers to human RNF222 due to the lack of specific data on mouse Rnf222.
STRING Interaction Network for Human RNF222: https://string-db.org/network/9606.ENSP00000382330
NIH Genetic Testing Registry for RNF222: https://www.ncbi.nlm.nih.gov/gtr/genes/643904/
Mouse Genome Database for Rnf222: https://www.informatics.jax.org/marker/MGI:2443227
Mouse RNF222 (Ring finger protein 222) is a protein encoded by the Rnf222 gene (Gene ID: 320040) in Mus musculus with UniProt ID Q8CEF8 . As a RING finger protein, it likely possesses E3 ubiquitin ligase activity, although its specific substrates and functional roles are still being characterized. The protein contains the characteristic RING domain which coordinates zinc ions and mediates protein-protein interactions critical for ubiquitination processes.
When expressed recombinantly, RNF222 is typically produced as a full-length or partial-length protein with various affinity tags (commonly His-tag) to facilitate purification . The recombinant protein is available in either liquid form or as a lyophilized powder with purity typically exceeding 80%, with endotoxin levels below 1.0 EU per μg as determined by the LAL method .
For optimal stability and activity, recombinant mouse RNF222 requires proper storage conditions:
Short-term storage (up to 2 weeks): Store at +4°C in PBS buffer
When working with the protein:
Minimize freeze-thaw cycles to prevent protein degradation
Thaw aliquots on ice and keep samples cold during handling
For reconstitution of lyophilized powder, use sterile, cold PBS buffer
After reconstitution, centrifuge briefly to collect the solution at the bottom of the tube
The protein is typically stable for at least one week when stored at 4°C, though activity may gradually decrease
| Storage Condition | Temperature | Maximum Storage Duration | Buffer Recommendation |
|---|---|---|---|
| Short-term | +4°C | 1-2 weeks | PBS buffer |
| Long-term | -20°C to -80°C | Several months to years | PBS with 20-50% glycerol |
| Working solution | On ice | <8 hours | Application-dependent |
Recombinant mouse RNF222 can be utilized in various research contexts:
Protein-protein interaction studies: Identifying binding partners through pull-down assays, co-immunoprecipitation, or yeast two-hybrid screens
Ubiquitination assays: Examining potential E3 ligase activity and substrate specificity
Structural biology: Crystallization trials or NMR studies to determine protein structure
Antibody production: Generating and validating antibodies against mouse RNF222
Enzymatic activity assays: Characterizing potential catalytic functions
When designing experiments, researchers should consider the specific tag used in the recombinant protein and its potential influence on protein folding, activity, and interactions. For interaction studies, it's advisable to use multiple approaches to validate findings, as single methodologies may yield false positives or negatives.
To study the E3 ligase activity of RNF222, consider implementing the following experimental approach:
In vitro ubiquitination assay protocol:
Prepare reaction mixture containing:
Recombinant RNF222 (200-500 ng)
E1 ubiquitin-activating enzyme (100-200 ng)
E2 ubiquitin-conjugating enzyme panel (test multiple E2s initially)
Ubiquitin (1-5 μg)
ATP regeneration system (2 mM ATP, 10 mM creatine phosphate, 3.5 U/ml creatine kinase)
Reaction buffer (50 mM Tris-HCl pH 7.5, 5 mM MgCl₂, 2 mM DTT)
Incubate at 30°C for 1-2 hours
Stop reaction with SDS-PAGE sample buffer
Analyze by western blotting using anti-ubiquitin antibodies
Drawing parallels from research on other RING finger proteins, such as the MuRF2-mediated ubiquitination of PPARγ1 at lysine 222 , can provide methodological insights. MuRF2 studies have demonstrated successful approaches to identifying specific ubiquitination sites using computational prediction, immunoprecipitation, ubiquitination assays, and cycloheximide chase experiments .
CRISPR/Cas9 technology offers powerful approaches to study RNF222 function through gene knockout or modification. Based on established protocols, researchers should consider:
Design multiple guide RNAs targeting RNF222: At least two gRNA constructs are recommended to increase success probability . The Zhang laboratory at the Broad Institute has designed efficient gRNAs targeting the RNF222 gene with minimal off-target effects .
Vector selection considerations:
Validation strategies:
Genomic PCR and sequencing to confirm mutations
Western blotting to verify protein knockdown
RT-qPCR to assess mRNA levels
| Experimental Strategy | Advantages | Limitations | Validation Methods |
|---|---|---|---|
| Complete knockout | Clear loss-of-function phenotype | May be lethal if essential | Genomic sequencing, Western blot |
| Conditional knockout | Temporal/tissue control | More complex design | PCR, Western blot, tissue-specific analysis |
| Knock-in tags | Study endogenous protein | May affect protein function | IP-MS, imaging of tagged protein |
| Point mutations | Study specific domains | Requires precise editing | Sequencing, functional assays |
Advanced structural bioinformatics approaches can significantly enhance our understanding of RNF222 function:
Template-based structure prediction: Tools like StarFunc combine template-based and deep learning approaches for protein function prediction . These methods can:
Perform fast Foldseek-based structure prefiltering
Select related templates for full-length TM-align alignment
Provide insights into structural features and potential functional domains of RNF222
Structure-function analysis workflow:
Identify conserved domains through sequence analysis
Generate structural models using homology modeling or AI-based approaches
Predict binding pockets and functional sites
Compare with structures of well-characterized RING finger proteins to infer functional capabilities
The RING domain of RNF222 likely adopts a cross-brace arrangement coordinating two zinc ions, similar to other RING finger proteins. This structural feature is critical for recruiting E2 ubiquitin-conjugating enzymes and facilitating ubiquitin transfer to substrates.
Identifying physiological substrates of E3 ubiquitin ligases like RNF222 presents significant challenges. A comprehensive experimental approach should include:
Proximity-based labeling:
Express BioID or TurboID-fused RNF222 in relevant cell types
Identify proximal proteins through streptavidin pulldown and mass spectrometry
Filter candidates based on enrichment scores and biological relevance
Ubiquitinome analysis:
Compare global ubiquitination patterns in RNF222 knockout vs. wild-type cells
Utilize diGly-lysine antibodies to enrich ubiquitinated peptides
Perform quantitative proteomics to identify differentially ubiquitinated proteins
Validation criteria:
Direct interaction with RNF222 (co-IP, GST-pulldown)
Increased ubiquitination in presence of RNF222
Reduced ubiquitination in RNF222 knockout/knockdown
Identification of specific ubiquitination sites
Drawing on approaches used for other RING finger proteins, researchers should consider methodologies similar to those used in characterizing MuRF2-mediated ubiquitination, which successfully identified lysine 222 as the key ubiquitination site in PPARγ1 .
Post-translational modifications (PTMs) often regulate E3 ligase activity. To study PTMs of RNF222:
PTM identification workflow:
Immunoprecipitate endogenous or tagged RNF222 from tissues/cells
Perform mass spectrometry analysis to identify PTMs
Focus on phosphorylation, SUMOylation, acetylation, and auto-ubiquitination
Functional impact assessment:
Generate site-specific mutants (e.g., phospho-mimetic or phospho-deficient)
Compare E3 ligase activity using in vitro ubiquitination assays
Assess protein stability through cycloheximide chase experiments
Examine subcellular localization through immunofluorescence
Analyze protein interaction changes using co-IP or proximity labeling
Kinase identification (for phosphorylation):
In vitro kinase assays with candidate kinases
Inhibitor studies in cell culture
Bioinformatic prediction of kinase recognition motifs
Understanding PTM regulation of RNF222 may reveal mechanisms for controlling its activity in different cellular contexts and physiological conditions.
When designing experiments with recombinant RNF222, include these essential controls:
Negative controls:
Catalytically inactive mutant (mutation in RING domain)
Heat-denatured protein
Empty vector or irrelevant protein with matching tag
Positive controls:
Well-characterized RING E3 ligase (if studying ubiquitination)
Known interaction partners of similar RING proteins (for interaction studies)
Validation controls:
Multiple independent batches of recombinant protein
Different expression systems (bacterial, insect, mammalian)
Alternative affinity tags to rule out tag interference
Specificity controls:
Competitive binding with untagged protein
Dose-dependent effects
Substrate specificity assessment with multiple potential targets
These controls help distinguish true biological activities from artifacts related to the recombinant protein preparation or experimental conditions.
Following standard scientific publication practices for data presentation will enhance the clarity and impact of RNF222 research:
Data table formatting best practices:
Clearly label independent variables (e.g., experimental conditions) and dependent variables (measured outcomes)3
Include appropriate units of measurement for all numeric data
Present standard deviations or standard errors
Use consistent significant figures throughout
Merge cells for multi-column headers to improve visual organization3
Figure preparation guidelines:
Plot independent variables on the x-axis and dependent variables on the y-axis
Include clear labels with units
Provide detailed figure legends explaining experimental conditions
Use consistent color schemes throughout the manuscript
Include statistical significance indicators
| Type of Experiment | Independent Variable | Dependent Variable | Typical Units | Recommended Controls |
|---|---|---|---|---|
| Ubiquitination assay | Enzyme concentration | Ubiquitination level | ng/μL or nM | Catalytically inactive mutant |
| Protein-protein interaction | Protein concentration | Binding affinity | μM (Kd) | GST/His tag only |
| Protein stability | Time after CHX addition | Remaining protein | % of initial | Vehicle treatment |
| Gene expression | Treatment condition | mRNA level | Fold change | Non-targeting control |
Researchers frequently encounter specific challenges when working with RING finger proteins like RNF222:
Protein solubility issues:
Challenge: RING domain proteins may aggregate due to improper zinc coordination
Solution: Include zinc in purification buffers (10-50 μM ZnCl₂), optimize expression temperature (16-18°C), consider fusion tags (MBP, SUMO) to enhance solubility
E3 ligase activity detection:
Challenge: Weak or undetectable activity in vitro
Solution: Test multiple E2 enzymes, optimize buffer conditions (pH, salt, reducing agents), consider adding zinc, ensure protein is not oxidized
Substrate identification difficulties:
Challenge: Non-specific binding in pulldown assays
Solution: Use stringent washing conditions, include competitors, perform sequential purification steps, validate with multiple approaches
Antibody specificity:
Challenge: Cross-reactivity with other RING proteins
Solution: Validate antibodies using knockout controls, use epitope-tagged versions, confirm key findings with multiple antibodies
Differentiating the unique functions of RNF222 from other RING finger proteins requires targeted experimental approaches:
Domain-specific analysis:
Identify unique domains or motifs outside the RING domain
Create chimeric proteins by swapping domains between RNF222 and related proteins
Perform structure-function analysis to correlate specific structural elements with functional outcomes
Tissue/cell-type specificity:
Analyze expression patterns across tissues using RT-qPCR
Perform immunohistochemistry to determine cellular and subcellular localization
Investigate cell-type specific phenotypes using conditional knockout models
Substrate specificity determination:
Compare ubiquitination targets with closely related RING proteins
Identify specific recognition motifs in substrates
Use competition assays to evaluate substrate preference
When designing CRISPR-based approaches to study RNF222 function, researchers should carefully validate guide RNA specificity to ensure they don't inadvertently target homologous regions in related RING finger proteins .